Publications by authors named "Aitor Azkarate"

Claim this Profile
A
A real‑world study of clinical characteristics, treatment sequence and outcomes of patients with non-small cell lung cancer and EGFR exon 20 insertion mutations.
Guillermo Suay, Paloma Martín-Martorell, Francisco Aparisi, María Arnal, María Guirado

Clin Transl Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.
Dolores Isla, Rosa Álvarez, María Arnal, Edurne Arriola, Aitor Azkarate

J Med Econ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Felipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Virginia Arrazubi, Raquel Hernandez, Aitor Azkarate

Gastric Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, Maria Alsina, Ana Custodio, Aitor Azkarate

Ther Adv Med Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Eva Martínez de Castro, Ana Custodio, Carles Pericay Pijaume

Gastric Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of the G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR.
Margalida Esteva-Socias, Mónica Enver-Sumaya, Cristina Gómez-Bellvert, Mónica Guillot, Aitor Azkárate

Front Med (Lausanne)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
Almudena Cotes Sanchís, Javier Gallego, Raquel Hernandez, Virginia Arrazubi, Ana Custodio

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.
Patricia Mondelo-Macía, Carmela Rodríguez-López, Laura Valiña, Santiago Aguín, Luis León-Mateos

Cells· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Marcelo Garrido, Ana Custodio, Raquel Hernandez

Thromb Haemost· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Isabel Echavarria, Manuel Sánchez Cánovas, Gema Aguado, Aitor Azkarate

Eur J Surg Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis.
Laura Visa, Paula Jiménez-Fonseca, Elena Asensio Martínez, Raquel Hernández, Ana Custodio, Aitor Azkarate

J Geriatr Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights in non-small-cell lung cancer: circulating tumor cells and cell-free DNA.
Elena Duréndez-Sáez, Aitor Azkárate, Marina Meri, Silvia Calabuig-Fariñas, Cristóbal Aguilar-Gallardo

J Thorac Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
Paula Jiménez Fonseca, Alberto Carmona-Bayonas, Raquel Hernández, Ana Custodio, Juana Maria Cano, Aitor Azkarate

Br J Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.
Paula Jiménez-Fonseca, Alberto Carmona-Bayonas, Maria Luisa Sánchez Lorenzo, Javier Gallego Plazas, Ana Custodio, Aitor Azkarate

Gastric Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry.
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Maria Luisa Sánchez Lorenzo, Avinash Ramchandani, Elena Asensio Martínez, Aitor Azkarate

J Natl Compr Canc Netw· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis